Biomedical moldings

Details for Australian Patent Application No. 2005293729 (hide)

Owner Novartis AG

Inventors Winterton, Lynn Cook

Agent Davies Collison Cave

Pub. Number AU-B-2005293729

PCT Pub. Number WO2006/040130

Priority 60/618,157 13.10.04 US

Filing date 11 October 2005

Wipo publication date 20 April 2006

Acceptance publication date 11 December 2008

International Classifications

G02B 1/04 (2006.01) Optical elements characterised by the material of which they are made - made of organic materials, e.g. plastics

C08L 29/04 (2006.01) Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an alcohol, ether, aldehydo, ketonic, acetal, or ketal radical

Event Publications

19 April 2007 PCT application entered the National Phase

  PCT publication WO2006/040130 Priority application(s): WO2006/040130

11 December 2008 Application Accepted

  Published as AU-B-2005293729

9 April 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005293733-Generic electronic laboratory notebook

2005293727-PVA hydrogel